BeStock  
Stocks › Biotechnology › PTGX

Protagonist Therapeutics PTGX

US equityMarket cap rank #1605Biotechnology
$121.40 −$2.62 (-2.11%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $121.40 0.00%
Open$123.41
Prev close$124.02
Day range$120.15 – $125.91
Volume600.7K
Market cap$7.92B
P/E (TTM)25.7
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$180.00+48.3% vs. price
  • Buy 100%
Low $151.00Now $121.40Avg $180.00High $221.00

Recent rating changes

The last 20 actions on file set price targets from $151.00 to $221.00, averaging $181.26.

DateFirmRatingTarget
10 Nov 2026 UBS BUY $184.00
9 Nov 2026 Wedbush BUY $173.00
9 Nov 2026 BMO Capital BUY $190.00
9 Nov 2026 J.P. Morgan BUY $151.00
6 Nov 2026 H.C. Wainwright BUY $221.00
6 Nov 2026 Barclays BUY $180.00
5 Nov 2026 BMO Capital BUY $190.00
3 Nov 2026 UBS BUY $184.00
2 Nov 2026 UBS BUY $184.00
21 Oct 2026 TD Cowen BUY $160.00
15 Oct 2026 Citi BUY $182.00
13 Oct 2026 Barclays BUY $180.00
12 Oct 2026 UBS BUY $184.00
12 Oct 2026 Leerink Partners BUY $190.00
11 Oct 2026 UBS BUY $184.00
9 Sep 2026 Citi BUY $182.00
1 Sep 2026 Truist Financial BUY –
1 Sep 2026 Citi BUY $182.00
1 Sep 2026 H.C. Wainwright BUY $170.00
31 Aug 2026 Clear Street BUY $173.00

Discussion

No comments yet — be the first to weigh in on PTGX.

Sign in to join the discussion.

Scroll to Top